Literature DB >> 22515108

Adipocytokines and obesity-linked disorders.

Noriyuki Ouchi1, Koji Ohashi, Rei Shibata, Toyoaki Murohara.   

Abstract

Obesity is closely associated with an increased risk for metabolic and cardiovascular diseases. Adipose tissue produces a number of secretory bioactive substances, also known as adipocytokines or adipokines, which directly affect adjacent or distant organs. Most adipocytokines are pro-inflammatory, thereby promoting the obesity-linked disorders. In contrast, there are a small number of adipocytokines that exhibit antiinflammatory properties. It is now recognized that dysregulated production or secretion of adipocytokines caused by adipocyte dysfunction leads to the development of obesity-linked complications. In this review, we focus on the functional role of several adipocytokines in metabolic and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515108      PMCID: PMC4831247     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  75 in total

1.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

2.  Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats.

Authors:  Y Hattori; K Akimoto; S S Gross; S Hattori; K Kasai
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 3.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

4.  Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.

Authors:  I Shimomura; T Funahashi; M Takahashi; K Maeda; K Kotani; T Nakamura; S Yamashita; M Miura; Y Fukuda; K Takemura; K Tokunaga; Y Matsuzawa
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

5.  Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats.

Authors:  Hiroaki Satoh; M T Audrey Nguyen; Maria Trujillo; Takeshi Imamura; Isao Usui; Philipp E Scherer; Jerrold M Olefsky
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

6.  Adiponectin replenishment ameliorates obesity-related hypertension.

Authors:  Koji Ohashi; Shinji Kihara; Noriyuki Ouchi; Masahiro Kumada; Koichi Fujita; Aki Hiuge; Toshiyuki Hibuse; Miwa Ryo; Hitoshi Nishizawa; Norikazu Maeda; Kazuhisa Maeda; Rei Shibata; Kenneth Walsh; Tohru Funahashi; Iichiro Shimomura
Journal:  Hypertension       Date:  2006-05-01       Impact factor: 10.190

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

9.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  24 in total

Review 1.  Omental transplantation for neuroendocrinological disorders.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2015-09-10

Review 2.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

3.  Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.

Authors:  Gloria Komazin; Michael Maybin; Ronald W Woodard; Thomas Scior; Dominik Schwudke; Ursula Schombel; Nicolas Gisch; Uwe Mamat; Timothy C Meredith
Journal:  J Biol Chem       Date:  2019-11-08       Impact factor: 5.157

4.  Anandamide-derived prostamide F2α negatively regulates adipogenesis.

Authors:  Cristoforo Silvestri; Andrea Martella; Neil J Poloso; Fabiana Piscitelli; Raffaele Capasso; Angelo Izzo; David F Woodward; Vincenzo Di Marzo
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

5.  Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  Hepatol Int       Date:  2012-10-26       Impact factor: 6.047

6.  LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model.

Authors:  Salvatore Chirumbolo; Guido Franceschetti; Elena Zoico; Clara Bambace; Luciano Cominacini; Mauro Zamboni
Journal:  Inflamm Res       Date:  2014-02-14       Impact factor: 4.575

7.  Ecological momentary assessment of urban adolescents' technology use and cravings for unhealthy snacks and drinks: differences by ethnicity and sex.

Authors:  Nicholas Borgogna; Ginger Lockhart; Jerry L Grenard; Tyson Barrett; Saul Shiffman; Kim D Reynolds
Journal:  J Acad Nutr Diet       Date:  2014-12-04       Impact factor: 4.910

8.  Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease.

Authors:  Apostolos Perelas; Vanessa Safarika; Ioannis S Vlachos; Irene Tzanetakou; Laskarina-Maria Korou; Panagiotis Konstantopoulos; Ilias Doulamis; Ioannis Ioannidis; Ioannis Kornezos; Dimitrios Gargas; Christos Klonaris; Despina N Perrea; Achilleas Chatziioannou
Journal:  Lipids Health Dis       Date:  2012-10-01       Impact factor: 3.876

9.  Coacervate whey protein improves inflammatory milieu in mice fed with high-fat diet.

Authors:  Mayara Franzoi Moreno; Gabriel Inácio de Morais Honorato de Souza; Ana Claudia Losinskas Hachul; Bruno Dos Santos; Marcos Hiromu Okuda; Nelson Inácio Pinto Neto; Valter Tadeu Boldarine; Elisa Esposito; Eliane Beraldi Ribeiro; Claudia Maria da Penha Oller do Nascimento; Aline de Piano Ganen; Lila Missae Oyama
Journal:  Nutr Metab (Lond)       Date:  2014-03-28       Impact factor: 4.169

10.  Targeting metabolic disorders by natural products.

Authors:  Bagher Larijani; Mohammad Abdollahi; Ozra Tabatabaei-Malazy
Journal:  J Diabetes Metab Disord       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.